PRETERM BIRTH and LOW BIRTH WEIGHT Preterm Birth (I.E
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
2018 Infant Mortality Annual Report 2 Ohio Infant Mortality Report 2018 TABLE of CONTENTS
2018 Infant Mortality Annual Report 2 Ohio Infant Mortality Report 2018 TABLE OF CONTENTS EXECUTIVE SUMMARY 4 SECTION 1: GENERAL FINDINGS 5-10 Ohio Infant Mortality Rate by Race and Ethnicity (2016-2018) 5 Trends in Ohio Infant Mortality (2009-2018) 6 Ohio Five-Year Average Infant Mortality Rates by County 8 Neonatal and Postneonatal Mortality Rates 9-10 SECTION 2: A DEEPER LOOK 11-19 Infant Mortality by Duration of Gestation and Birthweight 11-12 Risk Factors among Ohio Infant Deaths 13-14 Leading Causes of Infant Deaths 15-16 Prematurity-Related Infant Deaths 17 External Injury-Related Infant Deaths 18 Deaths to Infants Less Than 24 Weeks Gestation 19 DATA SOURCES AND METHODS 20 DEFINITIONS 21-22 REFERENCES 23 APPENDICES 24-45 Appendix A: The Ohio Equity Institute (OEI) 24-25 Appendix B: Sleep-Related Deaths 26-29 Appendix C: Supplementary Data Tables 30-45 Section 1: County-Level Infant Mortality Data 30-36 Section 2: A Deeper Look 37-45 3 EXECUTIVE SUMMARY Ohio has identified infant mortality as a priority in its 2017-2019 State Health Improvement Plan (SHIP)1. Infant mortality is the death of an infant before his or her first birthday. The Infant Mortality Rate is the number of infant deaths per 1,000 live births. The Infant Mortality Rate not only serves as a key indicator of maternal and infant health but is also an important measure of the health status of a community. In 2018, the infant mortality rate fell to 6.9 from 7.2 in 2017 for all races. -
Low Birthweight
OECD Health Statistics 2021 Definitions, Sources and Methods Low birthweight Number of live births weighing less than 2500 grams as a percentage of the total number of live births. Sources and Methods Australia Source: Australian Institute of Health and Welfare. From 1991: Australia’s mothers and babies reports available to download at https://www.aihw.gov.au/reports- statistics/population-groups/mothers-babies/reports. - From 2013 onwards, the Australian Institute of Health and Welfare has produced the data. - From 1991 to 2012, the National Perinatal Epidemiology and Statistics Unit produced the data on behalf of the Australian Institute of Health and Welfare. Before 1991: State and Territory maternal and perinatal collections. Break in time series in 1991: Before 1991, data refer to selected states and territories only and have total births (live births + stillbirths) as a denominator. Further information: https://www.aihw.gov.au/reports-statistics/population-groups/mothers-babies/overview. Austria Source: Statistics Austria, Gesundheitsstatistisches Jahrbuch (Health Statistics Report), Lebendgeborene nach Geburtsgewicht (Live births by birth weight) (several issues). Further information: http://www.statistik.at/web_en/. Belgium Source: Federal Public Service Economic Affairs - Directorate General for statistical and economic information (former National Statistical Institute). Methodology: Since 2010, the official numbers for livebirths and deaths are coming from the Population National Register (and not exclusively from vital registration). Livebirths and deaths of residents taking place in foreign countries are therefore included in the statistics. Canada Source: Statistics Canada. Canadian Vital Statistics Birth Database. From 1979: Table 13-10-0404-01 (formerly CANSIM 102-4005). 1961-1978: Births, 1991, Cat. No. -
Safety of Immunization During Pregnancy a Review of the Evidence
Safety of Immunization during Pregnancy A review of the evidence Global Advisory Committee on Vaccine Safety © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. -
Intrauterine Growth Retardation
eona f N tal l o B a io n l r o u g y o J Murki and Sharma, J Neonatal Biol 2014, 3:3 Journal of Neonatal Biology DOI: 10.4172/2167-0897.1000135 ISSN: 2167-0897 Review Article Open Access Intrauterine Growth Retardation - A Review Article Srinivas Murki* and Deepak Sharma Department of Neonatology, Fernandez Hospital, Hyderabad, India *Corresponding author:Srinivas Murki, Department of Neonatology, Fernandez Hospital, Hyderabad, India, Tel: +91 - 40 – 40632300; E-mail: [email protected] Rec date:Feb 09, 2014;Acc date: Mar 24, 2014;Pub date:Mar 26, 2014 Copyright: © 2014Murki S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Intrauterine growth restriction (IUGR) is defined as fetal growth less than the normal growth potential of a specific infant because of genetic or environmental factors. The terms IUGR and Small for Gestational Age (SGA) are often used alternatively to describe the same problem, although there exists subtle differences between the two. The burden of IUGR is concentrated mainly in Asia which accounts for nearly 75% of all affected infants. Various maternal, placental, neonatal, environmental and genetic factors are contributing to the preponderance of IUGR infants in Asia. These newborns are unique because of their peculiar and increased risk of immediate and long term complications in comparison with the appropriate gestational age born infants. In this review we would like to present the types of IUGR infants; possible etiology related to maternal, fetal and placental causes; short term and long term neurodevelopmental outcomes, and evidence based preventive interventions effective in reducing the IUGR burden. -
Maine Infant and Perinatal Health
MAINE INFANT AND PERINATAL HEALTH Strengths Challenges th 9 in 10 Maine infants are 10 highest born full-term (8.7% premature at <37 smoking rate during pregnancy th weeks; 7 lowest prematurity rate in the U.S.) (13% of women smoke during pregnancy; rate has been declining.) 7% of infants are born weighing less than 2,500 gram. (low birthweight; 80 infant deaths on average th 13 lowest in the U.S.) occur each year. Maine had the 18th th highest infant mortality rate in the U.S. 9 lowest teen in 2016 (5.7 per 1,000); 8th highest rate among White, Non-Hispanics (2014-2016); birth rate in the U.S. (13.1 per 1,000 Rate has been improving. aged 15-19); the rate has been declining steadily since the 1990s. 37% of new mothers in Maine 1 in 3 infants are breastfed did not intend to get pregnant or exclusively for 6 months. (5th were unsure if they wanted to be highest in the U.S.); 85% have ever been pregnant (trend is improving). breastfed (19th in the U.S.). 85% of infants are most often 1 in 11 new mothers in placed to sleep on their backs. Maine used marijuana during (14% increase since 2004; 6th highest in the pregnancy. U.S.); only 35% usually put their infants to sleep on an approved surface and 44% put their infants to sleep without loose or soft bedding. Almost 1,000 infants are reported as born drug affected each year; of 28 states, Maine had the 2nd highest rate of neonatal abstinence syndrome in 2013. -
Very Low Birth Weight Infants
Intensive Care Nursery House Staff Manual Very Low and Extremely Low Birthweight Infants INTRODUCTION and DEFINITIONS: Low birth weight infants are those born weighing less than 2500 g. These are further subdivided into: •Very Low Birth Weight (VLBW): Birth weight <1,500 g •Extremely Low Birth Weight (ELBW): Birth weight <1,000 g Obstetrical history (LMP, sonographic dating), newborn physical examination, and examination for maturational age (Ballard or Dubowitz) are critical data to differentiate premature LBW from more mature growth-retarded LBW infants. Survival statistics for ELBW infants correlate with gestational age. Morbidity statistics for growth-retarded VLBW infants correlate with the etiology and the severity of the growth-restriction. PREVALENCE: The rate of VLBW babies is increasing, due mainly to the increase in prematurely-born multiple gestations, in part related to assisted reproductive techniques. The distribution of LBW infants is shown in the Table: ________________________________________________________________________ Table. Prevalence by birth weight (BW) of LBW babies. Percentage of Percentage of Births Birth Weight (g) Total Births with BW <2,500 g <2,500 7.6% 100% 2,000-2,500 4.6% 61% 1,500-1,999 1.5% 20% 1,000-1,499 0.7% 9.5% 500-999 0.5% 7.5% <500 0.1% 2.0% ________________________________________________________________________ CAUSES: The primary causes of VLBW are premature birth (born <37 weeks gestation, and often <30 weeks) and intrauterine growth restriction (IUGR), usually due to problems with placenta, maternal health, or to birth defects. Many VLBW babies with IUGR are preterm and thus are both physically small and physiologically immature. RISK FACTORS: Any baby born prematurely is more likely to be very small. -
Maternal Contamination with Pcbs and Reproductive Outcomes in an Australian Population
Journal of Exposure Science and Environmental Epidemiology (2007) 17, 191–195 r 2007 Nature Publishing Group All rights reserved 1559-0631/07/$30.00 www.nature.com/jes Maternal contamination with PCBs and reproductive outcomes in an Australian population NARGES KHANJANI AND MALCOLM ROSS SIM Monash Centre for Occupational & Environmental Health, Department of Epidemiology & Preventive Medicine (Monash University), The Alfred Hospital, Melbourne, VIC, Australia Polychlorinated biphenyls used previously in industry are widespread environmental contaminants under scrutiny for their possible reproductive effects in humans. In this study, 200 breast milk samples from eligible Victorian mothers were used for measuring maternal contamination and their possible effect on the offspring was investigated. No significant association was found between maternal PCB contamination and low birth weight, small for gestational age and previous miscarriage or stillbirth. The elevated odd ratios of prematurity, increased with increase in contamination level but were nonsignificant. Higher PCB contamination was not in favor of any gender in the offspring. Our results suggest that chronic, low contamination with PCBs does not pose a reproduction threat in humans. Journal of Exposure Science and Environmental Epidemiology (2007) 17, 191–195. doi:10.1038/sj.jes.7500495; published online 14 June 2006 Keywords: polychlorinated biphenyls, PCBs, reproduction, birth weight, prematurity, sex ratio. Introduction caused developmental toxic effects in the litter of experi- -
Arizona Complete Health-Complete Care Plan Maternal Child Health
Maternal Child Health Special Edition Newsletter In This Issue Welcome to the Maternal Child Health Special Edition Newsletter. • Having a healthy baby At Arizona Complete Health-Complete Care Plan we understand how important your health care is to you and begins today your family. We want to help you along your path of being a new parent, connect you with resources, and provide the • Importance of care best care possible. • Dangers of Lead We want to thank you for being a member of Arizona • Tips for having a Complete Health-Complete Care Plan. healthy baby • Resources Covered services are funded under contract with AHCCCS. azcompletehealth.com/completecare Having a Healthy Baby Begins Today PREGNANCY AND COMMON DRUGS OR MEDICATIONS. What You Need to Know cause cognitive delay and birth defects in your baby. This Women who take common drugs or medications such as is called fetal alcohol syndrome. opioid pain medication need to be aware of the possible risks to themselves and their babies including Neonatal Drugs and alcohol during pregnancy may cause your baby Abstinence Syndrome (NAS). to go through withdrawal shortly after birth. Symptoms of withdrawal in babies can include: Ways to Prevent NAS • Seizures While you are pregnant make sure to: • Trembling or twitching • Meet with your Primary Care Provider (PCP) or • Irritability Obstetrician (OB) to make plans for your baby’s birth. • Diarrhea • Share any information about the medications, drugs, • Vomiting and other substances you are taking or have taken. • Fever • ASK before taking: • Continuous crying » Prescription Drugs » Over the counter medications Where To Go For Help » Herbal remedies Identifying prescription drug abuse and any substance » Sleep aids misuse as soon as possible is important. -
Low Birth Weight and Preterm Birth Pregnancy, Ohio, 2010 40
2014 Figure 1: Smoking Before, During, and After Pregnancy, Ohio, 2010 Low Birth Weight and Preterm Birth 40 Figure 1: Low Birth Weight and Preterm Singleton Health Impact 30 Births, Ohio, 2006-2011 70 > 38 Weeks+ 20 Infants born prior to 37 weeks of gestation are considered 60 Percent 30.9 preterm. Adverse health outcomes related to preterm birth include cerebral palsy, developmental delay, vision/hearing 10 21.8 50 16.3 impairment, and infant death from several causes, including SIDS.1 Preterm birth is a leading cause of infant mortality.1 40 0 37-38 Weeks- Almost half of preterm births are also of low birth weight 3 Months Before Last 3 Months of 2-6 Months After (LBW) , defined as weight less than 2,500 grams at birth. 30 Pregnancy Pregnancy Delivery* Preterm birth and fetal growth restrictions are the two main Births of Percent Source: Ohio Pregnancy Risk Assessment Monitoring System, Ohio Department of Health 2 20 - contributors to LBW births. Risk factors for LBW include 28-36 Weeks birth defects, fetal infection, maternal chronic health issues, alcohol or tobacco use, African-American race, and low 10 socioeconomic status.2 <2500 gm <28 Weeks+ 0 2006 2007 2008 2009 2010 2011 2012 Cost Impact Source: Ohio Department of Health Vital Statistics ⁺ Statistically significant increasing trend ⁻ Statistically significant decreasing trend Health care costs in the first year of life average 10 times higher for preterm than full-term infants. Accordingly, a Statistically significant decreases were observed in early term (37-38 preterm baby -
V5 Sectiona-FIMR 02-07-18.Xlsx
FIMR Report Form National Fatality Review Case Reporting System Version 5.0 Data entry website: https://data.ncfrp.org 1-800-656-2434 [email protected] www.ncfrp.org SAVING LIVES TOGETHER Instructions: This case report is used by Fetal and Infant Mortality Review (FIMR) teams to enter data into the National Fatality Review Case Reporting System (NFR-CRS). The NFR-CRS is available to states and local sites from the National Center for Fatality Review & Prevention (NCFRP) and requires a data use agreement for data entry. The purpose is to collect comprehensive information from multiple agencies participating in a review. The NFR-CRS documents demographics, the circumstances involved in the death, investigative actions, services provided or needed, key risk factors and actions recommended and/or taken by the team to prevent other deaths. While this data collection form is an important part of the FIMR process, it should not be the central focus of the review meeting. Experienced users have found that it works best to assign a person to record data while the team discussions are occurring. Persons should not attempt to answer every single question in a step-by-step manner as part of the team discussion. It is not expected that teams will have answers to all of the questions. However, over time abstractors and teams begin to understand the importance of data collection and will make efforts to incorporate necessary information into the case summary. The percentage of cases marked "unknown" and unanswered questions decreases as the team becomes more familiar with the form. The NFR-CRS Data Dictionary is available. -
Characteristics Associated with Failure to Complete The
Characteristics Associated with Failure to Complete the Pneumococcal Vaccine Series among Children with Sickle Cell Disease or Sickle Cell Trait Mary Kleyn, MSc, Violanda Grigorescu, MD, MSPH, Rachel Potter, DVM, MSc, Patricia Vranesich, RN, BSN, Robin O Neill, MPH, William Young, PhD, Robert Swanson, MPH Michigan Department of Community Health BACKGROUND METHODS CONCLUSIONS The Centers for Disease Control and Prevention (CDC) releases Age at time of vaccination was calculated using the birth date and vaccine date. Children with SCD had slightly higher pneumococcal vaccination series immunization schedules for various age groups that are approved by the Characteristics of those with SCD were compared to those of children with SCT using chi-square tests. completion rates compared to children with SCT, though both groups had Advisory Committee on Immunization Practices, the American Bivariate and multivariable logistic regression analyses were conducted to assess characteristics associated completion rates below 50%. Academy of Pediatrics, and the American Academy of Family with failure to complete the pneumococcal vaccine series. Physicians (Table 1).1 The immunization completion rates for the pneumococcal vaccination series should be improved for children with SCD given their increased risk for Children with sickle cell disease (SCD) are at increased risk of infections. acquiring invasive infections. RESULTS Select characteristics are associated with decreased likelihood of vaccine Timely completion of the pneumococcal vaccine series, defined as From 2004-2008, 291 newborns were diagnosed with SCD and 14,536 were reported as SCT. receipt among children with SCT, while no associations were found among receiving 4 pneumococcal vaccines by 15 months of age, could reduce Through linkages, approximately 97% of these newborns were matched with birth certificate records, and children with SCD. -
Neurosonographic Abnormalities Associated with Maternal History of Cocaine Use in Neonates of Appropriate Size for Their Gestational Age
Neurosonographic Abnormalities Associated with Maternal History of Cocaine Use in Neonates of Appropriate Size for Their Gestational Age Vikram Singh Dogra, Jaye M. Shyken, P. A. Menon, Jesse Poblete, Dina Lewis, and James S. Smeltzer PURPOSE: To determine whether increased incidence of neurosonographic abnormalities (pre dominantly of the basal ganglia and thalamus) in cocaine-exposed neonates who are small for their gestational age is attributable to the cocaine or to neonatal size. METHODS: Neonates whose sizes were appropriate for their gestational age with no evidence of hypoxia or respiratory distress were identified prospectively by a maternal history of cocaine use. Scans were performed within 72 hours of birth using a 7.5-MHz transducer following a standard protocol. The images were analyzed without access to patient information. Forty study neonates were compared with 34 control subjects who were appropriate in size for their gestational age, scanned using the same protocol. Comparisons were made using Fisher Exact Test, t test, and logistic regression. RESULTS: No control infant had neurosonographic abnormalities. In the study group, gestational age ranged from 27 to 41 weeks. Of the 40 study neonates, 14 (35 %) had one neurosonographic abnormality; two had two abnormalities. The predominant lesion was focal echolucencies, mainly in the area of the basal ganglia (10 of 40, 25%). Other findings were caudate echogenicity (3 of 40, 7.5%), ventricular dilation (2 of 40, 5%) and one "moth-eaten" appearance of the thalamus. Lesions were more likely approaching term and were not related to prematurity or alcohol use. CONCLUSION: Apparently normal neonates with a maternal history of cocaine use are likely to have degenerative changes or focal infarctions in their basal ganglia attributable to cocaine.